the prevalence of antinuclear antibodies was increased in patients with adenocarcinoma of the corpus uteri , chronic lesions of the cervix uteri , malignant melanoma , non-malignant pigmented skin lesions and basal cell carcinoma .
C1153706
adenocarcinoma of the
C0042149
uteri